AzTrials
AzTrials

AchalasiaNCT03228758

Anterior Orientation vs Posterior Orientation in Per Oral Endoscopic Myotomy POEM for the Treatment of Achalasia

A study testing Per Oral Endoscopic Myotomy in people with Achalasia, run by NYU Langone Health at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the safety and efficacy of the anterior versus posterior myotomy technique in Per Oral Endoscopic Myotomy (POEM) for the treatment of Achalasia. The primary efficacy outcome is periprocedural pain requiring the use of narcotics. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Achalasia
What is being tested?
Per Oral Endoscopic Myotomy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
89 participants
Where
1 siteUnited States
Study dates
24 Jul 2017to 24 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects who have been diagnosed with Achalasia Type I, II, or III by positive manometric findings and supporting findings by timed barium esophagram and endoscopy.
  • Subjects who are willing and competent to sign Informed Consent and to comply with study related visits and procedures.

Who cannot join

  • Subjects who are under 18 years of age
  • Subjects with Achalasia Type I, II, or III who have had a prior failed open or laparoscopic Heller myotomy; or have an esophageal diverticula, or anatomical variant dictating the approach of the myotomy
  • Subjects diagnosed with other motility disorders such as distal esophageal spasm (DES), hypertensive peristalsis (Nutcracker), or hypercontractile esophagus (Jackhammer)
  • Subjects with coagulopathy
  • Pregnant females
  • Subjects who in the investigators' opinion, are medically unstable , are unable to give informed consent, or whose risks outweigh the benefits of participating in the study
  • Subjects with decisional incapacity who are unable to comply with study related visits and procedures

Trial locations and contacts

1 site in 1 country.

United States1 site
  • NYU Winthrop Hospital

    Mineola, New York, 11501

Other trials in United States

About this study

Official title: Efficacy of Anterior Versus Posterior Myotomy Approach in Per Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia - A Single Operator Analysis

The purpose of this study is to compare the safety and efficacy of the anterior versus posterior myotomy technique in Per Oral Endoscopic Myotomy (POEM) for the treatment of Achalasia. The primary efficacy outcome is periprocedural pain requiring the use of narcotics. The secondary outcomes focus on safety which includes technical procedure duration time; tunneling time, myotomy time, and closure time; incidence of mucosotomy (transmural and non-transmural injury), capnoperitoneum, and the postoperative sequelae of gastrointestinal reflux disease (GERD). Periprocedural pain data collection will include post POEM procedure pain scores, administrations of analgesia until discharge.

The final analysis will focus on determining whether there is a statistically significant difference in the amount and severity of pain in the Anterior versus Posterior myotomy subject populations. Additional analysis will be the collection of analgesic type (narcotic versus non-narcotic), dosage, frequency, and duration of treatment from post POEM procedure in the endoscopy recovery suite until the subjects are discharged.

Read the detailed description

Achalasia is one of the most studied esophageal motility disorders. The etiology of Achalasia is autoimmune, neurodegenerative, or viral immune. Achalasia is a consequence of the degeneration of ganglion cells in the myenteric plexus of the esophageal body and the lower esophageal sphincter (LES). The end result of the inflammatory process is the loss of inhibitory neurotransmitters nitrous oxide and vasoactive intestinal peptide causing the imbalance between excitatory and inhibitory neurons. This results in failure of the lower esophageal sphincter (LES) to relax and is associated with aperistalsis of the esophageal body, leading to difficulty swallowing, food and fluid stasis; regurgitation of undigested food, fluid and saliva; and weight loss. Achalasia is an incurable disease and treatments are only focused on the relaxation of the lower esophageal sphincter in order to allow for passage of food fluid and saliva into the stomach. It has an estimated prevalence of 10 cases per 100,000 populations and an incidence of 1-3 cases per 100,000 populations per year in the Western world.

The armamentarium of Achalasia treatment includes pharmacologic management with the use of calcium channel blockers, nitrites, phosphodiesterase inhibitor (sildenafil), anticholinergics, and beta-adrenergic agonists; endoscopy using botulinum toxin injections just above the squamocolumnar junction or pneumatic balloon dilation of the lower esophageal sphincter; open Heller Myotomy, laparoscopic Heller Myotomy, and Per Oral Endoscopic myotomy (POEM). Per oral endoscopic myotomy (POEM) is the most recent innovative treatment in the armamentarium of Achalasia treatment. Per oral endoscopic myotomy (POEM) is a natural orifice transluminal endoscopic surgery (NOTES) approach to a Heller myotomy for the treatment of Achalasia. In 2008, POEM was first performed successfully in a human subject by Haruhiro Inoue in Japan. The POEM was performed on a 36 year old patient without any documented post-operative complications. In 2009, Stavros Stavropoulos at Winthrop University Hospital (WUH) performed the first per oral endoscopic myotomy (POEM) procedure outside of Japan. The POEM was performed on a 42 year old male without documented post-operative complications. The subject had a marked improvement in objective manometric and barium esophagram findings; and improvement in subjective dysphagia score. Consequently there has been a rapidly increasing volume of POEM procedures performed in Japan, China, and throughout the United States. Stavropoulos at Winthrop University Hospital has the highest single-operator volume in the United States. The performance of POEM is still in evolution with various centers around the world performing variations on technique.

The International Per Oral Endoscopic Myotomy Survey (IPOEMS) was conducted by Stavropoulos and Savides during the July 2012 annual meeting of Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR). This survey was conducted to address the scarceness of POEM literature at the time. IPOEM provided a "snapshot" of the status of POEM worldwide. The survey included 5 Asian, 7 North American, and 4 European expert centers with a combined total of 841 POEM procedures performed by July 2012. At the time most centers (14) performed right anterior myotomy (2 o'clock orientation) with only a few of centers performing posterolateral myotomy (5 o'clock orientation) determined using the usual endoscopic convention of 12 o'clock representing the most anterior aspect of the esophagus on endoluminal view.

The esophagus in humans is a complex structure with multiple muscles, nerves, vascular, and lymphatic components. Branches of the vagus nerve and visceral branches of the sympathetic trunk provide nerve fibers to the esophageal plexus. The vagus nerve delivers two fiber types to the esophageal plexus: preganglionic parasympathetic fibers and afferent fibers. These vagal fibers in the esophageal plexus reform to make the anterior vagal trunk (left vagus) and the posterior vagal trunk (right vagus). The anterior and posterior terms for the vagal trunks are used in relation to the esophagus. The visceral branches of the sympathetic trunk delivers two fiber types to the esophageal plexus: sympathetic postganglionic fibers and the afferent fibers. The afferent fibers originating from the sympathetic trunk are primarily involved with pain. The critical anatomical component of the esophagus in the treatment of Achalasia is the lower esophageal sphincter. Per common convention, the most anterior point of the LES point is assigned as the 12 o'clock position. The strong oblique sling fiber component is centered at 7o'clock on the posterolateral wall and wraps over the anterior and posterior walls at 11 o'clock and 5 o'clock, respectively. The weaker circular clasp fiber component location is centered at 2 o'clock to 3 o'clock. The question of investigating the optimal orientation to perform the myotomy is unique to POEM. Open Heller myotomy and laparoscopic Heller myotomy are limited to the anterior aspect of the esophagus. Myotomy orientation is constrained by the anatomical locations of the left bronchus, left atrium and spine. Anterior orientation is forced between the 1 o'clock - 2 o'clock position secondary to the locations of the left bronchus and left atrium between 10 o'clock -11 o'clock and 12 o'clock - 1 o'clock, respectively. Posterior orientation is forced between the 4 o'clock - 5 o'clock positions secondary to the location of the spine located between 8 o'clock-9 o'clock positions .The sling fibers maintain the angle of His and are a significant antireflux barrier. Stavropoulos et al, reported on a single operator series of 284 POEM subjects at Digestive Disease Week in May 2016. A statistical difference was found in the number of subjects requiring narcotics post POEM procedure Subjects who had an anterior myotomy were less likely to require narcotics post POEM procedure than those subjects who had a posterior myotomy, 35% versus 53% respectively (p=0.007).

To date, there have been no prospective randomized controlled studies conducted comparing anterior versus posterior myotomy technique in POEM analyzing perioperative pain, procedure duration, incidence of mucosotomy, capnoperitoneum, and the postoperative sequelae of gastrointestinal reflux disease (GERD).

Conditions
Achalasia
Being tested
Per Oral Endoscopic Myotomy
Keywords
POEM
Medical subject headings
Esophageal Achalasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Per Oral Endoscopic MyotomyProcedure or surgery

    The Per Oral Endoscopic Myotomy procedure is the cutting of the lower esophageal sphincter. This procedure is a natural orifice transluminal endoscopic surgery (NOTES)

Study groups in NCT03228758
Study groupRoleWhat they receive
Anterior OrientationActive comparatorThe anterior endoscopic myotomy of the lower esophageal sphincter will be performed between the 11 o'clock to 3 o'clock position in the esophagus determined by the usual endoscopic convention of 12 o'clock representing the most anterior aspect of the esophagus on endoluminal view. Intervention is the endoscopic myotomy of the lower esophageal sphincter.
Receives: Procedure: Per Oral Endoscopic Myotomy
Posterior OrientationActive comparatorThe posterior endoscopic myotomy of the lower esophageal sphincter will be performed between the 5 o'clock to 6 o'clock position in the esophagus determined by the usual endoscopic convention of 12 o'clock representing the most anterior aspect of the esophagus on endoluminal view. Intervention is the endoscopic myotomy of the lower esophageal sphincter.
Receives: Procedure: Per Oral Endoscopic Myotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Periprocedural pain requiring the use of narcotics.

    Pain related to the endoscopic myotomy requiring the use of narcotic pain medication.

    Measured: Within the first 48 hours after the procedure.

Secondary outcomes (1)
  1. Incidence of Gastrointestinal Reflux Disease (GERD)

    Gastrointestinal Reflux Disease measured by BRAVO pH study

    Measured: Within 3 months after the procedure.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2017
  2. Study start24 Jul 2017
  3. Primary completion18 May 2018
  4. Study completion24 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Subjects will be randomized to either the anterior or posterior orientation approach to the endoscopic myotomy.
Masking
Single blind
Who is masked
Participant
Enrolment
89 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03228758
Sponsor's protocol ID
WUH 17008
Other IDs
18-01666
Status last verified
May 2020
First submitted
13 Jul 2017
Last updated
5 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Nguyen NQ, Holloway RH. Recent developments in esophageal motor disorders. Curr Opin Gastroenterol. 2005 Jul;21(4):478-84.

    PubMed 15930992
  • Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol. 2013 Aug;108(8):1238-49; quiz 1250. doi: 10.1038/ajg.2013.196. Epub 2013 Jul 23.

    PubMed 23877351
  • Walzer N, Hirano I. Achalasia. Gastroenterol Clin North Am. 2008 Dec;37(4):807-25, viii. doi: 10.1016/j.gtc.2008.09.002.

    PubMed 19028319
  • Ruffato A, Mattioli S, Lugaresi ML, D'Ovidio F, Antonacci F, Di Simone MP. Long-term results after Heller-Dor operation for oesophageal achalasia. Eur J Cardiothorac Surg. 2006 Jun;29(6):914-9. doi: 10.1016/j.ejcts.2006.03.044. Epub 2006 May 3.

    PubMed 16675239
  • Ujiki MB, Yetasook AK, Zapf M, Linn JG, Carbray JM, Denham W. Peroral endoscopic myotomy: A short-term comparison with the standard laparoscopic approach. Surgery. 2013 Oct;154(4):893-7; discussion 897-900. doi: 10.1016/j.surg.2013.04.042.

    PubMed 24074429
  • Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010 Apr;42(4):265-71. doi: 10.1055/s-0029-1244080. Epub 2010 Mar 30.

    PubMed 20354937
  • Richter JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol. 2008 Jun;2(3):435-45. doi: 10.1586/17474124.2.3.435.

    PubMed 19072391
  • Stavropoulos SN, Harris MD, Hida S, Brathwaite C, Demetriou C, Grendell J. Endoscopic submucosal myotomy for the treatment of achalasia (with video). Gastrointest Endosc. 2010 Dec;72(6):1309-11. doi: 10.1016/j.gie.2010.04.016. No abstract available.

    PubMed 21111876
  • Stavropoulos SN, Modayil RJ, Friedel D, Savides T. The International Per Oral Endoscopic Myotomy Survey (IPOEMS): a snapshot of the global POEM experience. Surg Endosc. 2013 Sep;27(9):3322-38. doi: 10.1007/s00464-013-2913-8. Epub 2013 Apr 3.

    PubMed 23549760
  • Stavropoulos, SN, Modayil, R, and Brathwaite, et al. Anterior vs. posterior per oral endoscopic myotomy (POEM): Is there a difference in outcome? Gastrointest Endosc 2016; 83 (5S): AB145

  • Friedel D, Modayil R, Stavropoulos SN. Per Oral Endoscopic Myotomy (POEM): review of current techniques and outcomes (including postoperative reflux). Curr Surg Rep 2013; 1: 203-213.

  • Stranding, S. (2016) Mediastinum, In Gray's anatomy: the anatomical basis of clinical practice. (41st Ed.). (pp. 976-993) Elsevier Limited in Clinical Key Flex

Questions about this trial

What is this clinical trial studying?

A study testing Per Oral Endoscopic Myotomy in people with Achalasia, run by NYU Langone Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Periprocedural pain requiring the use of narcotics. (time frame: Within the first 48 hours after the procedure.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03228758, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in